Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECRETE-I: Luseogliflozin vs teneligliptin on beta-cell responsiveness in type 2 diabetes
jRCTs061190008Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in type 2 diabetes mellitus (T2DM) comparing Luseogliflozin arm with Teneligliptin arm (2 arms). Started Jul 2019; status: completed.
02
Drugs
luseogliflozinteneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs061190008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061190008.